Dr. Diana M. Schneider: In Memoriam - National Multiple Sclerosis Society

Skip to navigation Skip to content

News

Share

Dr. Diana M. Schneider: In Memoriam

November 19, 2013

The National MS Society has lost a great friend and long-time collaborator in disseminating advances in neurology and neuroscience, Dr. Diana M. Schneider.

Dr. Schneider received a Ph.D. in neurochemistry from UCLA. Subsequently she held academic positions at UCLA and MIT. Her unusual ability to communicate complex research findings clearly and concisely led both those institutions to send her to research meetings around the world and then to write summaries of the presentations for publication.

After serving as Editor-in-Chief of Raven Press, she founded two publishing companies, Demos and Diamedica, both of which focus on publishing books delivering practical information for patients of neurological and other disorders. She was frequently called upon to write for National MS Society publications and program materials.  Diana was also co-author of a handbook for people with primary-progressive MS.

Cyndi Zagieboylo, CEO of the National MS Society, wrote: "In addition to shepherding many books by Society authors through the publishing process, she gave permission for those materials to be available online for our Information Resource Center MS Specialists to use when responding to questions from people affected by MS. She helped build awareness about MS and its impact on individuals and families throughout her career -- a thoughtful, creative and generous pioneer in the MS movement."

Dr. Schneider died September 11, 2013.  She was 70.   She was predeceased three months earlier by her life companion, John Fowler, who had primary-progressive MS.  

About Multiple Sclerosis

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.

Share